Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer

Tumori

Volumn 92, Issue 4, 2006, Pages 327-333

  Alongi, Filippo ^a,e   Ragusa, Pietro ^b   Montemaggi, Paolo ^c   Bona, Cristina Maria ^d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Ospedale Oncologico M Ascoli   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

^e NONE   (Italy)

Author keywords

CT; Diagnostic odds ratio; Lung cancer; Mediastinal staging; Meta analysis; PET sensitivity; Specificity

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 33749506271     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200412     Document Type: Article

References (36)

1. Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, Blahd W, Williams AJ: Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med, 153: 417-421, 1996.
2. Egger M, Smith GD, Phillips AN: Meta-analysis: principles and procedures. BMJ, 315: 1533-1537, 1997.
3. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ, 326: 41-44, 2003.
4. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD: Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol, 3: 2-9, 2002.
5. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials, 7: 177-188, 1986.
6. Moses LE, Shapiro D, Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med, 12: 1293-1316, 1993.
7. Irwig L, Macaskill P, Glasziou P, Fahey M: Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol, 48: 119-130, 1995.
8. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA: Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer a prospective analysis of 50 cases. Chest, 112: 1480-1486, 1997.
9. Albes JM, Dohmen BM, Schott U, Schulen E, Wehrmann M, Ziemer G: Value of positron emission tomography for lung cancer staging. Eur J Surg Oncol, 28: 55-62, 2002.
10. Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr: Staging non-small cell lung cancer with whole-body PET. Radiology, 212: 803-809, 1999.
11. Richter JA, Torre W, Gamez C, Aramendia JM, Crespo A, Nicolas A, Brugarolas A: Value of Pet-18FDG in lung cancer. Med Clin Barc, 113: 567-571, 1999.
12. Kubota K, Imran MB, Ono S, Akaizawa T, Gotoh R, Fukuda H: Diagnostic value of whole-body positron emission tomography using fluorine-18 fluorodeoxyglucose for lung and other cancer. Jpn J Clin Radiol, 45: 199-208, 2000.
13. Pieterman RM, Van Putten JWG, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, Fidler V, Pruim J, Groen HJ: Preoperative staging of non-small cell lung cancer with positron-emission tomography. N Engl J Med, 343: 254-261, 2000.
14. Weng E, Tran L, Rege S, Safa A, Sadeghi A, Juillard G, Juillard G, Mark R, Santiago S, Brown C, Mandelkern M: Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol, 23: 47-52, 2000.
15. Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme PH: PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung cancer. Eur J Cardiothorac Surg, 20: 468-475, 2001.
16. Luketich JD, Friedman DM, Meltzer CC, Belani CP, Townsend DW, Christie NA, Weigel TL: The role of positron emission tomography in evaluating mediastinal lymph node metastases in non-small-cell lung cancer. Clin Lung Cancer, 2: 229-233, 2001.
17. Kiernan PD, Sheridan MJ, Lamberti J, Dicicco B, Wigton R, Hetrick V, Vaughan B, Graling P: Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography. South Med J, 95: 1168-1172, 2002.
18. Von Haag DW, Follette DM, Roberts PF, Shelton D, Segel LD, Taylor TM: Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer. J Surg Res, 103: 160-164, 2002.
19. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS: Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology, 2292: 526-533, 2003.
20. Halter G, Buck AK, Schirrmeister H, Aksoy E, Liewald F, Glatting G, Neumaier B, Muhling B, Nussle-Kugele K, Hetzel M, Sunder-Plassmann L, Reske SN: Lymph node staging in lung cancer using [18F]FDG-PET. Thorac Cardiovasc Surg, 522: 96-101, 2004.
21. Dales RE, Stark RM, Raman S: Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis, 141: 1096-1101, 1990.
22. McKenna R, Libshitz H, Mountain C, McMurtrey M: Roentgenographic evaluation of mediastinal nodes for preoperative assesment in lung cancer. Chest, 88: 206-210, 1985.
23. Webb WR, Gatsouris S, Zerhouni EA, Heelan RT, Blazer GM, Francis IR, McNeil BJ: CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiology Diagnostic Oncology Group. Radiology, 178: 705-713, 1991.
24. Schrevens L, Lorent N, Dooms C, Vansteenkiste J: The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist, 9: 633-643, 2004.
25. White PG, Adams H, Crane MD, Butchard Eg: Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours? Thorax, 49: 951-957, 1994.
26. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL: Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology, 213: 530-536, 1999.
27. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan GK, Owens DK: Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: a meta-analysis. Ann Intern Med, 139: 879-892, 2003.
28. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM: Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumours. Basis for discussion of the German Consensus Conference on PET in Oncology. Pneumologie, 55: 367-355, 2001.
29. Fischer BM, Mortensen J, Hojgaard L: Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol, 2: 659-666, 2001.
30. Toloza EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest, 123 (Suppl 1): 137-146, 2003.
31. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otoka T, Morikawa T, Kinoshita I, Dosaka-Akita H, Nishimura M: Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration, 70: 500-506, 2003.
32. Schmucking M, Baum RP, Bonnet R, Junker K, Muller KM: Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment. Pathology, 26: 178-189, 2005.
33. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC: Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med, 348 (25): 2500-2507, 2003.
34. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA: The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg, 78: 1017-1023, 2004.
35. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S: Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology, 236: 1011-1019, 2005.
36. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA, Maldonado A, Garcia de Barajas S, Calero-Garcia R, Pozo MA, Martin-Escribano P, Martin-Garcia I, Garcia-Lujan R, Lopez-Encuentra A, Arenas de Pablo A: Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer. J Clin Oncol, 23: 8348-8356, 2005.